| ISIN | CH0595227429 |
|---|---|
| Valor Number | 59522742 |
| Bloomberg Global ID | VRFSVEC SW |
| Fund Name | Raiffeisen Futura - Swiss Stock VE |
| Fund Provider |
Raiffeisen Schweiz Genossenschaft, St. Gallen
St. Gallen, Switzerland Phone: +41 71 225 98 78 E-Mail: fonds@raiffeisen.ch Web: www.raiffeisen.ch |
| Fund Provider | Raiffeisen Schweiz Genossenschaft, St. Gallen |
| Representative in Switzerland |
Raiffeisen Schweiz Genossenschaft St. Gallen Phone: +41 71 225 98 78 |
| Distributor(s) |
Raiffeisen Schweiz Genossenschaft St. Gallen Phone: +41 71 225 98 78 |
| Asset Class | Equities |
| EFC Category | Equity Switzerland |
| Distribution Policy | Accumulation |
| Home Country | Switzerland |
| Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | N/A |
| Peculiarities |
| Current Price * | 115.32 CHF | 19.11.2025 |
|---|---|---|
| Previous Price * | 114.62 CHF | 18.11.2025 |
| 52 Week High * | 119.60 CHF | 13.02.2025 |
| 52 Week Low * | 100.52 CHF | 09.04.2025 |
| NAV * | 115.32 CHF | 19.11.2025 |
| Issue Price * | 115.32 CHF | 19.11.2025 |
| Redemption Price * | 115.32 CHF | 19.11.2025 |
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 2,289,501,083 | |
| Unit/Share Assets *** | 629,816,905 | |
| Trading Information SIX | ||
| YTD Performance | +5.63% |
31.12.2024 - 19.11.2025
31.12.2024 19.11.2025 |
|---|---|---|
| 1 month | -1.04% |
20.10.2025 - 19.11.2025
20.10.2025 19.11.2025 |
| 3 months | -2.50% |
19.08.2025 - 19.11.2025
19.08.2025 19.11.2025 |
| 6 months | -1.64% |
19.05.2025 - 19.11.2025
19.05.2025 19.11.2025 |
| 1 year | +6.37% |
19.11.2024 - 19.11.2025
19.11.2024 19.11.2025 |
| 2 years | +17.14% |
20.11.2023 - 19.11.2025
20.11.2023 19.11.2025 |
| 3 years | +18.35% |
21.11.2022 - 19.11.2025
21.11.2022 19.11.2025 |
| 5 years | +19.89% |
25.02.2021 - 19.11.2025
25.02.2021 19.11.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Novartis AG Registered Shares | 12.16% | |
|---|---|---|
| Roche Holding AG | 11.80% | |
| ABB Ltd | 5.31% | |
| Zurich Insurance Group AG | 4.13% | |
| Sika AG | 3.61% | |
| Chocoladefabriken Lindt & Spruengli AG Ordinary Shares - Non Voting | 3.41% | |
| Lonza Group Ltd | 3.03% | |
| Alcon Inc | 2.93% | |
| Belimo Holding AG | 2.76% | |
| Swiss Re AG | 2.71% | |
| Last data update | 31.07.2025 | |
| TER | 0.30% |
|---|---|
| TER date | 31.01.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.40% |
| Ongoing Charges *** | 0.31% |
|
SRRI ***
|
|
| SRRI date *** | 31.10.2025 |